SPDR S&P Biotech ETF $XBI Shares Purchased by Kercheville Advisors LLC

Kercheville Advisors LLC boosted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,304 shares of the exchange traded fund’s stock after buying an additional 3,509 shares during the period. SPDR S&P Biotech ETF makes up about 1.2% of Kercheville Advisors LLC’s investment portfolio, making the stock its 25th largest position. Kercheville Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $4,463,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the business. Axiom Investment Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $26,000. Financial Life Planners acquired a new stake in shares of SPDR S&P Biotech ETF in the first quarter worth $27,000. Angeles Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth $28,000. SHP Wealth Management bought a new position in SPDR S&P Biotech ETF during the fourth quarter worth $31,000. Finally, Morling Financial Advisors LLC bought a new position in SPDR S&P Biotech ETF during the second quarter worth $36,000.

SPDR S&P Biotech ETF Price Performance

XBI stock traded up $3.54 on Monday, reaching $147.86. 8,385,527 shares of the company were exchanged, compared to its average volume of 9,182,575. The firm has a market capitalization of $10.21 billion, a PE ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 12 month low of $106.30 and a 12 month high of $169.89. The stock’s fifty day moving average price is $158.09 and its 200 day moving average price is $147.07.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.